KIORA PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
KIORA PHARMACEUTICALS, INC. (KPRX) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of 70.98 thousand shares as of 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber · last filed 2026-03-25
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 70.98K shares.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 46.70K shares.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 25.49K shares; Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number as first filed 229.37K shares.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 30.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number as first filed |
|---|---|---|
| 2025-12-31 | 70.98K shares 10-K · filed 2026-03-25 | |
| 2024-12-31 | 46.70K shares 10-K · filed 2026-03-25 | |
| 2023-12-31 | 25.49K shares 10-K · filed 2025-03-25 | 229.37K shares 10-K · filed 2024-03-25 |
| 2022-12-31 | 30.00K shares 10-K · filed 2024-03-25 | |
| 2022-09-30 | 1.66M shares 10-Q · filed 2022-11-09 | |
| 2022-06-30 | 6.31M shares 10-Q · filed 2022-08-12 | |
| 2022-03-31 | 6.76M shares 10-Q · filed 2022-07-08 | |
| 2021-12-31 | 375.00 shares 10-K · filed 2023-03-23 | 41.22K shares 10-K · filed 2022-04-15 |
| 2021-09-30 | 168.93K shares 10-Q · filed 2022-11-09 | |
| 2021-06-30 | 4.25M shares 10-Q · filed 2022-08-12 | |
| 2020-12-31 | 68.17K shares 10-Q · filed 2022-11-09 | 77.26K shares 10-K · filed 2021-03-25 |
| 2020-03-31 | 91.03K shares 10-Q · filed 2020-05-06 | |
| 2019-12-31 | 50.19K shares 10-K · filed 2021-03-25 | |
| 2019-09-30 | 58.48K shares 10-Q · filed 2019-11-07 | |
| 2019-06-30 | 1.81M shares 10-Q · filed 2019-08-08 | |
| 2019-03-31 | 120.94K shares 10-Q · filed 2020-05-06 | |
| 2018-12-31 | 121.48K shares 10-K · filed 2020-03-04 | |
| 2018-09-30 | 125.91K shares 10-Q · filed 2019-11-07 | |
| 2018-06-30 | 57.51K shares 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |